Drug-Eluting Balloons Versus Everolimus-Eluting Stents for In-Stent Restenosis: A Meta-Analysis of Randomized Trials
Highlights
- • Randomized trials comparing DEB versus EES for ISR were underpowered for clinical end-points.
- • This meta-analysis of 5 trials showed that DEB was associated with an increased risk of TVR and TLR at longer follow-up for any ISR.
- • The quality of evidence was moderate suggesting the need for further randomized trials with longer follow-up.
Abstract
Objectives
Individual randomized trials comparing drug-eluting balloons (DEB) versus everolimus-eluting stents (EES) for in-stent restenosis (ISR) were underpowered for clinical end-points. The objective of this study was to compare the clinical outcomes of DEB versus EES for any ISR.